Cipaglucosidase alfa

Definition: Cipaglucosidase alfa, sold under the brand name Pombiliti, and used in combination with miglustat, is a medication used for the treatment of glycogen storage disease type II (Pompe disease). Cipaglucosidase alfa is a recombinant human acid α-glucosidase enzyme replacement therapy that provides an exogenous source of acid α-glucosidase. The most common side effects include chills, dizziness, flushing, sleepiness, chest discomfort, cough, swelling at the infusion site and pain. source: Wikipedia

ID

1025331000122100

ID date

25 Apr 2025

Previous ID

42237811000001108

Name

Cipaglucosidase alfa